Loxo Oncology Inc buy melinda
Start price
26.10.17
/
50%
€76.97
Target price
19.01.18
€85.24
Performance (%)
11.25%
End price
19.01.18
€85.63
Summary
This prediction ended on 19.01.18 with a price of €85.63. The prediction had a final performance of 11.25%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Loxo Oncology Inc | - | - | - | - |
iShares Core DAX® | -3.033% | 0.651% | 12.268% | 18.187% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% | 47.279% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% | 10.489% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% | 45.572% |
Comments by melinda for this prediction
In the thread Loxo Oncology Inc diskutieren
ONKOLOGIE
Loxo Oncology, Inc.
Loxo Onkologie wird die Finanzergebnisse für das dritte Quartal bekannt geben 2017 und eine Telefonkonferenz mit dem Host
(Zielkurs erreicht)
Stopped prediction by melinda for Loxo Oncology Inc
Loxo Oncology Inc
Start price
Target price
Perf. (%)
€85.33
26.10.17
26.10.17
€94.50
19.01.18
19.01.18
11.25%
19.01.18
19.01.18